This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 53/1/57    most recent HYPERTENSIONAHA.108.118356v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bhuiyan, Md. S. Articles by Fukunaga, K. Search for Related Content PubMed PubMed Citation Articles by Bhuiyan, Md. S. Articles by Fukunaga, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cardiovascular Pharmacology Hypertrophy

(Hypertension. 2009;53:57.)
© 2009 American Heart Association, Inc.

Original Articles

Activation of Endothelial Nitric Oxide Synthase by a Vanadium Compound Ameliorates Pressure Overload-Induced Cardiac Injury in Ovariectomized Rats

Md. Shenuarin Bhuiyan; Norifumi Shioda; Masatoshi Shibuya; Yoshiharu Iwabuchi; Kohji Fukunaga

From the Departments of Pharmacology (M.S.B., N.S., K.F.) and Synthetic Chemistry (M.S., Y.I.), Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; and Tohoku University 21st Century Center of Excellence Program "CRESCENDO" (K.F.), Sendai, Japan.

Correspondence to Kohji Fukunaga, Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Japan. E-mail fukunaga{at}mail.pharm.tohoku.ac.jp

We here investigated the effect of bis(1-oxy-2-pyridinethiolato) oxovanadium (IV), [VO(OPT)], against myocardial hypertrophy and cardiac functional recovery in pressure overload–induced hypertrophy in ovariectomized female rats and defined mechanisms underlying its cardioprotective action. Wistar rats subjected to bilateral ovariectomy were further treated with abdominal aortic stenosis. VO(OPT) (containing 1.25 and 2.50 mg of vanadium per kg) was administered orally once a day for 14 days starting from 2 weeks after aortic banding. Treatment with VO(OPT) significantly inhibited pressure overload–induced increase both in the heart weight:body weight ratio and the lung weight:body weight ratio. VO(OPT) also attenuated hypertrophy-induced impaired left ventricular end-diastolic pressure, left ventricular developed pressure, and left ventricular contractility (±dp/dt_max). VO(OPT) treatment significantly restored pressure overload–induced impaired endothelial NO synthase activity with concomitant increased phosphorylation of endothelial NO synthase (Ser1179). Moreover, VO(OPT) treatment significantly restored pressure overload–induced reduced Akt activity, as indicated by increased phosphorylation at Ser473 and at Thr308. Treatment with VO(OPT) also secondarily inhibited calpastatin and dystrophin breakdown and decreased myosin light chain phosphorylation. Finally, VO(OPT) treatment significantly attenuated mortality after repeated isoproterenol administration in pressure overloaded–ovariectomized rats. Taken together, VO(OPT) attenuates cardiac myocytes hypertrophy in vivo in pressure overload–induced hypertrophy in ovariectomized rats and prevents the process from hypertrophy to heart failure. These effects are mediated by inhibition of calpastatin and dystrophin breakdown in addition to increased Akt and endothelial NO synthase activities.

Key Words: myocardial hypertrophy • protein kinase B (Akt) • endothelial nitric oxide synthase (eNOS) • ovariectomy • dystrophin